Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-02-28

FDA Approved: PREGNYL — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for PREGNYL (choriogonadotropin alfa) filed by Organon LLC, resulting in labeling changes for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREGNYL (Chorionic gonadotropin alfa)

Snippet

SUPPL AP for PREGNYL (CHORIOGONADOTROPIN ALFA)